自主无监督治疗计划首次应用于前列腺癌自适应MR引导放疗
本研究首次在人体中验证了一种集成于在线自适应MR引导放疗的自主无监督治疗计划方法,用于一名中危前列腺癌患者。自动分割与自动计划优化均无需人工干预,基线计划满足12/16项剂量学标准但均在容差内,在线自适应时满足14/16项标准。首次人工干预仅发生在在线计划自适应阶段,表明该流程可行并可能缩短模拟到放疗开始的间隔。
要点
- 深度学习自动分割OAR和靶区耗时3分钟,自动计划优化耗时300分钟。
- 自主基线计划满足12/16项剂量学标准,全部在预设容差内。
- 在线MRgRT自适应时满足14/16项标准,首次人工干预在该阶段。
核心结论
- 自主无监督数据准备与治疗计划首次在人体中证明对自适应MRgRT可行并成功应用。
- 首次人工干预的检查点设定在在线MRgRT计划自适应时。
- 自主计划缩短了模拟到放疗开始的时间延迟,未来可能支持实时MRgRT应用。
研究设计与样本
- 首例人体经验研究,对象为一名中危前列腺癌患者。
- 使用深度学习软件和逻辑体积算子自动分割OAR和靶区。
- 基于1.5 T MR-Linac自动生成基线计划(20x3 Gy),采用粒子群优化(PSO)且无人工交互。
- 计划质量用预定义剂量学标准(含适当容差)评估,在线自适应时设为首个人工交互检查点。
主要发现
- OAR和靶区成功分割耗时3分钟,并用于自动计划优化耗时300分钟。
- 自主生成计划满足12/16项剂量学标准,但全部保持在容差内。
- 未经人工验证的基线计划成功用于在线MRgRT计划自适应,满足14/16项标准。
- 如预期,人工交互仅在计划自适应期间需要。
关键数值与推荐
- 基线计划满足12/16项预定义剂量学标准,全部在容差内。
- 在线MRgRT自适应时满足14/16项剂量学标准。
- 自动分割耗时3分钟,自动计划优化耗时300分钟。
- 基线计划剂量为20x3 Gy,基于1.5 T MR-Linac。
临床怎么用
- 自主无监督计划流程可作为在线自适应MRgRT的基础,减少人工交互环节。
- 人工干预可集中在在线计划自适应阶段,作为质量控制检查点。
- 该流程可能缩短从模拟定位到放疗开始的间隔,为未来实时MRgRT应用提供条件。
局限性
- 为首例人体经验,仅报告一名中危前列腺癌患者。
- 基线计划未满足全部16项剂量学标准(满足12项)。
- 自主计划优化耗时300分钟,可能限制即时临床应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Currently clinical radiotherapy (RT) planning consists of a multi-step routine procedure requiring human interaction which often results in a time-consuming and fragmented process with limited robustness. Here we present an autonomous un-supervised treatment planning approach, integrated as basis for online adaptive magnetic resonance guided RT (MRgRT), which was delivered to a prostate cancer patient as a first-in-human experience. MATERIALS AND METHODS: For an intermediate risk prostate cancer patient OARs and targets were automatically segmented using a deep learning-based software and logical volume operators. A baseline plan for the 1.5 T MR-Linac (20x3 Gy) was automatically generated using particle swarm optimization (PSO) without any human interaction. Plan quality was evaluated by predefined dosimetric criteria including appropriate tolerances. Online plan adaptation during clinical MRgRT was defined as first checkpoint for human interaction. RESULTS: OARs and targets were successfully segmented (3 min) and used for automatic plan optimization (300 min). The autonomous generated plan satisfied 12/16 dosimetric criteria, however all remained within tolerance. Without prior human validation, this baseline plan was successfully used during online MRgRT plan adaptation, where 14/16 criteria were fulfilled. As postulated, human interaction was necessary only during plan adaptation. CONCLUSION: Autonomous, un-supervised data preparation and treatment planning was first-in-human shown to be feasible for adaptive MRgRT and successfully applied. The checkpoint for first human intervention was at the time of online MRgRT plan adaptation. Autonomous planning reduced the time delay between simulation and start of RT and may thus allow for real-time MRgRT applications in the future.
引用
- Künzel LA, Nachbar M, Hagmüller M, et al. First experience of autonomous, un-supervised treatment planning integrated in adaptive MR-guided radiotherapy and delivered to a patient with prostate cancer. Radiother Oncol. 2021. PMID: 33812912. doi:10.1016/j.radonc.2021.03.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。